Press I. Reprogramming the Enemy Within: Patient-Derived CAR-T Cells Effectively Target Inflammation-Inducing B cells. MJUSc [Internet]. 2025 Sep. 22 [cited 2026 Mar. 2];4(1):13-4. Available from: https://journals.ku.edu/MJUSc/article/view/24543